Scientific Publications

New aspects in the pathophysiology of preeclampsia

J.M. Davison
V. Homuth
A. Jeyabalan
K.P. Conrad
S.A. Karumanchi
S. Quaggin
R. Dechend
F.C. Luft

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

D.C. Gulba
M. Praus
R. Dechend
S. Hauck
M. Mahler
R. Zitvz
B. Baldus
W. Mueller
R. Dietz

AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor

R. Dechend
V. Homuth
G. Wallukat
J. Kreuzer
J.K. Park
J. Theuer
A. Juepner
D.C. Gulba
N. Mackman
H. Haller
F.C. Luft

July 01, 2000 / Am J Pathol

Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

D.N. Mueller
E.M.A. Mervaala
R. Dechend
A. Fiebeler
J.K. Park
F. Schmidt
J. Theuer
V. Breu
N. Mackman
T. Luther
W. Schneider
D. Gulba
D. Ganten
H. Haller
F.C. Luft

A gene for hypotrichosis simplex of the scalp maps to chromosome 6p21.3

R.C. Betz
Y.A. Lee
A. Bygum
F. Brandrup
A.I. Bernal
J. Toribio
J.I. Alvarez
G.M. Kukuk
H.H.W. Ibsen
H.B. Rasmussen
T.F. Wienker
A. Reis
P. Propping
R. Kruse
S. Cichon
M.M. Noethen

Localization of a gene for syndactyly type 1 to chromosome 2q34-q36

K. Bosse
R.C. Betz
Y.A. Lee
T.F. Wienker
A. Reis
H. Kleen
P. Propping
S. Cichon
M.M. Noethen

Antihypertensive Behandlung. Bei Risikopatienten von Anfang an fix kombinieren [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?]

R. Dechend
W. Derer
D.N. Mueller

Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia

K.B. Brosnihan
L. Hering
R. Dechend
M.C. Chappell
F. Herse

Vitronectin concentrations predict risk in patients undergoing coronary stenting

W. Derer
E.S. Barnathan
E. Safak
P. Agarwal
H. Heidecke
M. Moeckel
M. Gross
C. Oezcelik
R. Dietz
R. Dechend

Circulating and uteroplacental adipocytokine concentrations in preeclampsia

F. Herse
Y. Bai
A.C. Staff
Y.M. Jiang
R. Dechend
R. Zhou